March 27th 2020
Tassili Life Sciences, Corp. Has Been Acquired By Champignon Brands
Tassili Life Sciences, Corp. in collaboration with multiple university research institutes intends to prove that clinical and physiological effectiveness in post concussion syndrome, PTSD and OCD are enhanced by timely measured dosages of Psilocybin+CBD with superior clinical results as measured by objective outcomes.
We expect this combination to elicit clinical outcomes that are superior to Psilocybin or CBD alone.
Our vision is to administer the compounds of Psilocybin and Cannabis-THC and/or CBD in certified drug and talk therapy clinics. Using treatment protocols and professionally trained personnel collaboratively appointed with our university research institute partners, consistent with the highest patient safety standards, reviewed and approved by pertinent regulators including the FDA.